Plain-English translation of NCT06927024 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called transcutaneous auricular vagus nerve stimulation (taVNS), which uses a small device to gently stimulate a nerve in your ear. Researchers believe this stimulation may help improve how your nervous system and heart function in people with chronic kidney disease stages 3–5. The study will compare the real treatment to a sham (fake) treatment to see if it's safe and whether it actually works.
People with chronic kidney disease often have problems with their nervous system that can affect heart health and overall well-being. This treatment may help restore balance to the nervous system in a simple, non-invasive way—but researchers need to test whether it truly works before offering it more widely.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive either the real ear stimulation treatment or a sham treatment. For two weeks, you will use the device for 15 minutes each morning at home. The study team will monitor your health and measure how your nervous system and heart respond to see if the treatment is safe and effective.
AI-generated summary from trial data · Jun 21, 2026 · Not medical advice
United States
Sponsor
NYU Langone Health
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Enrollment target
~30 participants
Started
October 2025
Primary completion
January 2029
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Qandeel Soomro, MD
NYU Langone Health
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.